Amphetamines.com Call Now. 800-816-1059

Comparative oral and topical decongestant effects of phenylpropanolamine and d-pseudoephedrinene

by Erickson CH, McLeod RL, Mingo GG, Egan RW, Pedersen OF, Hey JA.
Allergy, Schering-Plough Research Institute, Kenilworth, New Jersey 07033-0539, USA.
Am J Rhinol 2001 Mar-Apr;15(2):83-90

ABSTRACT

Nonselective adrenergic alpha-agonists such as phenylpropanolamine and d-pseudoephedrine are widely used as decongestants to treat nasal congestion associated with a variety of nasal diseases. Although the activity of these drugs is well established in clinical studies, a direct comparison of their nasal decongestant effect as determined by changes in nasal cavity dimensions and nasal architecture has not been studied. Using acoustic rhinometry, we evaluated the effects of these drugs on nasal cavity volume, minimum cross-sectional area (Amin), and the distance from the nosepiece to the Amin (Dmin) in a feline, pharmacological model of nasal congestion. Administration of topical compound 48/80 (1%), a mast cell histamine liberator, into the left nasal passageway decreased nasal volume by 66%, reduced Amin by 51%, and increased Dmin by 116%. The congestive responses to compound 48/80 (1%) were reproducible through six weeks. In a subset of cats, the nasal cavity volume effect of repetitive exposure to compound 48/80, given once every two weeks for six weeks, was not different from the nasal responses after the initial exposure to compound 48/80. Pretreatment with oral phenylpropanolamine (10 mg/kg) or oral d-pseudoephedrine (10 mg/kg) attenuated the nasal effects of compound 48/80, but were associated with a pronounced increase in systolic blood pressure of +51 and +82 mmHg, respectively. A similar decongestant profile was observed with phenylpropanolamine (1%) and d-pseudoephedrine (1%) when given topically. Topical phenylpropanolamine (1%) and d-pseudoephedrine 1%) 45 minutes after dosing increased blood pressure +44 and +17 mmHg, respectively, over control animals. We conclude that oral and topical phenylpropanolamine and d-pseudoephedrine display equieffective nasal decongestant activity and produce similar cardiovascular profiles characterized by significant increases in blood pressure.


Get Free Help Today

Get Help Now - Confidential & Free
Call now for:
  • Access to Free and Paid Alternatives
  • 24 Hour Support when YOU need it
  • Local Drug & Alcohol Resources
800-816-1059

Related Articles

Cocaine or Amphetamines: Which Recovery Program is More Difficult?

Learn More

What is Projection and How does it Affect Your Recovery Efforts?

Learn More

Avoiding Relapse: Tips For Taking Your Mind Off Cravings

Learn More

How Do I Tell My Parents I Need Amphetamine Addiction Help?

Learn More
Exit mobile version